Invesco EQQQ NASDAQ 100 ETF
How can you add US equity exposure to your portfolio through a different route than the S&P 500? The Invesco EQQQ NASDAQ-100 UCITS ETF (EQQQ) is the largest and oldest NASDAQ-100 tracker in Europe. It gives you access to 100 of the largest and most innovative non-financial companies listed in the US. With a focus on growth stocks in the technology, consumer, and healthcare sectors, an investment in EQQQ is an investment in companies that are driving the world’s most advanced research and development. The ETF has a strong track record and an ongoing charge of just 0.30% per annum, offering you the potential to diversify your US equity portfolio.
View our other nominated ETFs
- Invesco EURO STOXX 50 ETF (European Equity - Passive Category)
- Invesco S&P 500 ETF (North American Equity - Passive Category)
- Invesco MSCI World ETF (Global Equity - Passive Category)
- Invesco Technology S&P US Select Sector ETF (Technology/Biotech - Passive Category)
The value of investments and any income will fluctuate (this may partly be the result of exchange rate fluctuations) and investors may not get back the full amount invested.
The Fund will not replicate the performance of its Reference Index perfectly, this is because the Fund will incur drags on performance such as expenses and transactions costs, which the Reference Index is not subject to. If the Fund is unable to hold the securities in the exact proportion required this will affect its ability to track the Reference Index.
When making an investment in an ETF you are buying shares in a company, which are generally considered high risk investments and may result in fluctuations in the value of the Fund due to external factors.
Return on your investment may be adversely affected by variations in exchange rates.
Your capital is at risk. You may not get back the amount you invested.
Any investment in the products should be made on the basis of the relevant Prospectus, Key Investor Information Document or Key Information Document (the “offering documents”), and it should include a consideration of the investment objective, risks, charges and expenses. The offering documents as well as further information on the products (including information on their portfolio composition) are available at etf.invesco.com, or from your financial adviser or broker.
This information is marketing material and is not intended as investment advice or as a recommendation to invest in any particular asset class, security or strategy. The information provided is for illustrative purposes only, and it should not be relied upon as investment advice or as a recommendation to buy or sell securities. Investors should seek independent professional advice prior to investing.
NASDAQ® and NASDAQ-100 IndexSM are trade/service marks of The Nasdaq Stock Market, Inc. (which with its affiliates is referred to as the "Corporations") and are licensed for use by Invesco. The Product(s) have not been passed on by the Corporations as to their legality or suitability. The Product(s) are not issued, endorsed, sold, or promoted by the Corporations. THE CORPORATIONS MAKE NO WARRANTIES AND BEAR NO LIABILITY WITH RESPECT TO THE PRODUCT(S).
This information has been communicated by Invesco UK Services Limited, Perpetual Park, Perpetual Park Drive, Henley-on-Thames, Oxfordshire, RG9 1HH authorised and regulated by the Financial Conduct Authority, and Invesco Asset Management Limited, Perpetual Park, Perpetual Park Drive, Henley-on-Thames, Oxfordshire, RG9 1HH, United Kingdom. Authorised and regulated by the Financial Conduct Authority.
© 2018 Invesco. All rights reserved.